Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

R. Park, Julie; G. Kreissman, Susan; B. London, Wendy; Naranjo, Arlene; L. Cohn, Susan; D. Hogarty, Michael; C. Tenney, Sheena; A. Haas‐Kogan, Daphne; J. Shaw, Peter; M. Kraveka, Jacqueline; S. Roberts, Stephen; D. Geiger, James; J. Doski, John; D. Voss, Stephan; M. Maris, John; A. Grupp, Stephan; Diller, Lisa

doi:10.1001/jama.2019.11642

Public

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

Published in JAMA • Aug 27, 2019

Authors:

Julie R. Park

Susan G. Kreissman

Wendy B. London

Abstract

Importance: Induction chemotherapy followed by high-dose therapy with autologous stem cell transplant and subsequent antidisialoganglioside antibody immunotherapy is standard of care for patients with high-risk neuroblastoma, but survival rate among these patients remains low. Objective: To determin...

Subject

Medicine

Neuroblastoma

Stem cell

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!